Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glibenclamide Posttreatment Does Not Inhibit Levcromakalim Induced Headache in Healthy Participants: A Randomized Clinical Trial

Published:2023-03 Issue:2 Volume:20 Page:389-398
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Kokoti Lili,Al-Karagholi Mohammad Al-Mahdi,Waldorff Nielsen Cherie Amalie,Ashina Messoud

Funder

Lundbeckfonden

Lundbeck Foundation Professor Grant

Rigshospitalet

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-023-01350-y.pdf

Reference36 articles.

1. Ropper AH, editor;Migraine;N Engl J Med,2020

2. Latest insights into the pathophysiology of migraine: the ATP-sensitive potassium channels;Kokoti;Curr Pain Headache Rep.,2020

3. KATP channels in pig and human intracranial arteries;Ploug;Eur J Pharmacol,2008

4. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues;Ploug;Eur J Pharmacol,2010

5. Levcromakalim, an adenosine triphosphate-sensitive potassium channel opener, dilates extracerebral but not cerebral arteries;Al-Karagholi;Headache,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal Models of Chronic Migraine: From the Bench to Therapy;Current Pain and Headache Reports;2024-07-02

2. Non-vascular ATP-sensitive potassium channel activation does not trigger migraine attacks: A randomized clinical trial;Cephalalgia;2024-05

3. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial;Cephalalgia;2024-01

4. Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial;Pain;2023-12-19

5. The shortcoming of using glibenclamide in exploratory clinical headache provocation studies;Cephalalgia;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3